# Photronics Inc: Form 10-Q for the period ended May 3, 2020

- Company: [Photronics Inc](/companies/plab.md) (CIK 810136)
- Form: 10-Q
- Filed: 2020-06-12
- Accepted by EDGAR: Jun 12, 2020, 16:44 ET
- Period: 2020-05-03
- Accession: 0001140361-20-013682
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/810136/000114036120013682/form10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/810136/000114036120013682/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-05-03.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2020-02-03 to 2020-05-03 | $142.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months, 2019-11-01 to 2020-05-03 | $302.5m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2020-02-03 to 2020-05-03 | $112.3m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months, 2019-11-01 to 2020-05-03 | $237.5m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2020-02-03 to 2020-05-03 | $30.4m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2019-11-01 to 2020-05-03 | $65.0m | us-gaap:GrossProfit |
| Research and development | 3 months, 2020-02-03 to 2020-05-03 | $4.5m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2019-11-01 to 2020-05-03 | $8.5m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2020-02-03 to 2020-05-03 | $13.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2019-11-01 to 2020-05-03 | $27.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2020-02-03 to 2020-05-03 | $12.7m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2019-11-01 to 2020-05-03 | $29.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2020-02-03 to 2020-05-03 | $3.8m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2019-11-01 to 2020-05-03 | $12.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2020-02-03 to 2020-05-03 | $6.3m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2019-11-01 to 2020-05-03 | $16.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2020-02-03 to 2020-05-03 | $0.10 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2019-11-01 to 2020-05-03 | $0.25 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2020-02-03 to 2020-05-03 | $0.10 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2019-11-01 to 2020-05-03 | $0.25 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2020-02-03 to 2020-05-03 | 65,417,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2019-11-01 to 2020-05-03 | 65,933,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2019-11-01 to 2020-05-03 | $61.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2019-11-01 to 2020-05-03 | $30.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 6 months, 2019-11-01 to 2020-05-03 | $16.9m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2020-05-03 | $237.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2020-05-03 | $472.3m | us-gaap:AssetsCurrent |
| Total assets | at 2020-05-03 | $1.13bn | us-gaap:Assets |
| Current liabilities | at 2020-05-03 | $153.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2020-05-03 | $212.2m | us-gaap:Liabilities |
| Long-term debt | at 2020-05-03 | $35.8m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2020-05-03 | $7.8m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | at 2020-05-03 | $9.9m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2020-05-03 | $769.2m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 33,124 characters.

### Overview

Management's discussion and analysis ("MD&A") of the Company's financial condition, results of operations and outlook should be read in conjunction with its condensed consolidated financial statements and related notes. Various segments of this MD&A contain forward-looking statements, all of which are presented based on current expectations, which may be adversely affected by uncertainties and risk factors (presented throughout this filing and in the Company's Annual Report on Form 10-K for the fiscal 2019 year), that may cause actual results to materially differ from these expectations.

We sell substantially all of our photomasks to semiconductor designers and manufacturers, and manufacturers of FPDs. Photomask technology is also being applied to the fabrication of other higher-performance electronic products such as photonics, microelectronic mechanical systems and certain nanotechnology applications. Our selling cycle is tightly interwoven with the development and release of new semiconductor and FPD designs and applications, particularly as they relate to the semiconductor industry's migration to more advanced product innovation, design methodologies, and fabrication processes. We believe that the demand for photomasks primarily depends on design activity rather than sales volumes from products manufactured using photomask technologies. Consequently, an increase in semiconductor or FPD sales does not necessarily result in a corresponding increase in photomask sales. However, the reduced use of customized ICs, reductions in design complexity, other changes in the technology or methods of manufacturing or designing semiconductors, or a slowdown in the introduction of new semiconductor or FPD designs could reduce demand for photomasks ‒ even if the demand for semiconductors and FPDs increases. Advances in semiconductor, FPD, and photomask design and semiconductor and FPD production methods that shift the burden of achieving device performance away from lithography could also reduce the demand for photomasks. Historically, the microelectronic industry has been volatile, experiencing periodic downturns and slowdowns in design activity. These downturns have been characterized by, among other things, diminished product demand, excess production capacity, and accelerated erosion of selling prices, with a concomitant effect on revenue and profitability.

We are typically required to fulfill customer orders within a short period of time after receipt of an order, sometimes within twenty-four hours. This results in a minimal level of backlog orders, typically one to two weeks of backlog for IC photomasks and two to three weeks of backlog for FPD photomasks.

The global semiconductor and FPD industries are driven by end markets which have been closely tied to consumer-driven applications of high-performance devices, including, but not limited to, mobile display devices, mobile communications, and computing solutions. While we cannot predict the timing of the industry's transition to volume production of next-generation technology nodes, or the timing of up and down cycles with precise accuracy, we believe that such transitions and cycles will continue into the future, beneficially and adversely affecting our business, financial condition, and operating results as they occur. We believe our ability to remain successful in these environments is dependent upon the achievement of our goals of being a service and technology leader and efficient solutions supplier, which we believe should enable us to continually reinvest in our global infrastructure.

### Recent Developments

In the first quarter of fiscal 2020, we acquired the remaining 0.2% of noncontrolling interests in Photronics Cheonan, Ltd. (formerly PK, Ltd.), our South Korean subsidiary, for $0.6 million.

In the first quarter of fiscal 2020, we adopted ASU 2016-02 and all subsequent amendments, collectively codified in Accounting Standards Codification Topic 842 - “Leases” (“Topic 842”). This guidance requires modified retrospective adoption, either at the beginning of the earliest period presented or at the beginning of the period of adoption; we elected to apply the guidance at the beginning of the period of adoption, and recognized right-of-use leased assets of $6.5 million and corresponding lease liabilities which were discounted at our incremental borrowing rates, on our November 1, 2019 condensed consolidated balance sheet to reflect our adoption of the guidance. Our adoption of Topic 842 did not affect our cash flows or our ability to comply with covenants under our credit agreements.

In the fourth quarter of fiscal 2019, our board of directors declared a dividend of one preferred stock purchase right (a “Right”), payable on or about October 1, 2019, for each share of common stock, par value $0.01 per share, of the Company outstanding on September 30, 2019, to the stockholders of record on that date. In connection with the distribution of the Rights, we entered into a Section 382 Rights Agreement (the “Rights Agreement”), dated as of September 23, 2019, between the Company and Computershare Trust Company, N.A., a federally chartered trust company, as rights agent. The purpose of the Rights Agreement is to deter trading of our common stock that would result in a change in control (as defined in Internal Revenue Code Section 382), thereby preserving our future ability to use our historical federal net operating losses and other Tax Attributes (as defined in the Rights Agreement). Each Right entitles the registered holder to purchase from the Company one one-thousandth of a share of Series A Preferred Stock, par value $0.01 per share, at a price of $33.63, subject to adjustment. The Rights, which are described in the Company’s Current Report on Form 8-K filed on September 24, 2019, are in all respects subject to and governed by the provisions of the Rights Agreement. The Rights will expire at the earliest to occur of (i) the close of business on the day following the date on which our board of directors determines, in its sole discretion, that the Rights Agreement is no longer necessary for the preservation of material valuable tax attributes, or the tax attributes have been fully utilized and may no longer be carried forward or (ii) the close of business on September 22, 2022.

In the fourth quarter of fiscal 2019, PDMC, the Company’s majority-owned IC subsidiary in Taiwan, paid a dividend of which 49.99%, or approximately $18.9 million, was paid to noncontrolling interests.

In the fourth quarter of fiscal 2019, upon our request, a financing entity made an advance payment of $3.5 million to an equipment vendor. We entered into a Master Lease Agreement (“MLA”) with this financing entity, which became effective in July 2019. The MLA enables us to request advance payments or other funds to finance equipment to be leased or purchased in the U.S. In connection with this MLA, we have been approved for financing of $35 million for the purchase of a high-end lithography tool. Interest on this borrowing is payable monthly at thirty-day LIBOR plus 1% (1.79% at May 3, 2020), and will continue to accrue until the borrowing is repaid or, as allowed under the MLA, we enter into a lease for the equipment. We intend to enter into a lease agreement for the related equipment in fiscal year 2020.

In the fourth quarter of fiscal 2019, the Company’s board of directors authorized the repurchase of up to $100 million of its common stock, pursuant to a repurchase plan under Rule 10b5-1 of the Securities Act of 1933 (as amended). We repurchased 2.5 million shares, at a cost of $27.9 million (an average price of $11.34 per share), under this authorization. All shares repurchased during fiscal 2019 (0.9 million) were retired in fiscal 2019; the repurchase program was terminated on March 20 2020.

In the second quarter of fiscal 2019, we repaid, upon maturity, the entire $57.5 million principal amount of the convertible senior notes we issued in April 2016.

In the first quarter of fiscal 2019, PDMC paid a dividend, of which 49.99%, or approximately $26.1 million, was paid to noncontrolling interests.

In the first quarter of fiscal 2019, PDMCX was approved for credit of the equivalent of $50 million, subject to certain limitations related to PDMCX registered capital at the time of the initial approval, pursuant to which PDMCX has and will enter into separate loan agreements (“the Project Loans”) for intermittent borrowings. The Project Loans, which are denominated in Chinese renminbi (RMB), are being used to finance certain capital expenditures in China. PDMCX granted liens on its interest in land, building, and certain equipment as collateral for the Project Loans. As of May 3, 2020, PDMCX had borrowed 243.4 million RMB ($34.5 million) against this approval. Payments on these borrowings are due semi-annually through December 2025; the initial payment is scheduled for June 2020. See Note 5 of the condensed consolidated financial statements for additional information on these loans.

In the first quarter of fiscal 2019, PDMCX received approval for unsecured credit of the equivalent of $25.0 million, pursuant to which PDMCX may enter into separate loan agreements. Under this credit agreement, PDMCX can borrow up to 140.0 million RMB to pay value-added taxes (“VAT”) and up to 60.0 million RMB to fund operations; combined total borrowings are limited to the equivalent of $25.0 million. As of May 3, 2020, PDMCX had outstanding 44.8 million RMB ($6.3 million) to fund operations, with repayments due one year from the borrowing dates of the separate loan agreements. As of May 3, 2020, PDMCX had outstanding 64.6 million RMB ($9.1 million) borrowed to pay VAT. Payments on these borrowings are due semiannually, in increasing amounts, through January 2022. See Note 5 of the condensed consolidated financial statements for additional information on these loans.

In the fourth quarter of fiscal 2018, the Company’s board of directors authorized the repurchase of up to $25 million of its common stock, to have been executed in open-market transactions or in accordance with a repurchase plan under Rule 10b5-1 of the Securities Act of 1933 (as amended). The share repurchase program commenced, under Rule 10b5-1, on October 22, 2018, and was terminated on February 1, 2019. We repurchased 1.5 million shares at a cost of $13.8 million (an average of $9.41 per share) under this authorization.

### Results of Operations

### Three and Six-Months ended May 3, 2020

The following table presents selected operating information expressed as a percent of revenue.

|  | Three Months Ended May 3, 2020 | February 2, 2020 | April 28, 2019 | Six Months Ended May 3, 2020 | April 28, 2019 |
| --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 78.7 | 78.3 | 80.2 | 78.5 | 79.7 |
| Gross profit | 21.3 | 21.7 | 19.8 | 21.5 | 20.3 |
| Selling, general and administrative expenses | 9.3 | 8.9 | 10.1 | 9.2 | 10.6 |
| Research and development expenses | 3.1 | 2.6 | 2.7 | 2.7 | 3.0 |
| Operating income | 8.9 | 10.2 | 7.0 | 9.6 | 6.7 |
| Other income (expense), net | (0.7) | 2.3 | 3.0 | 0.9 | 2.0 |
| Income before income taxes | 8.2 | 12.5 | 10.0 | 10.5 | 8.7 |
| Income tax provision | 2.6 | 5.7 | 2.5 | 4.3 | 1.8 |
| Net income | 5.6 | 6.8 | 7.5 | 6.2 | 6.9 |
| Net income attributable to noncontrolling interests | 1.2 | 0.4 | 1.1 1.1 | 0.7 | 1.5 |
| Net income attributable to Photronics, Inc. shareholders | 4.4% | 6.4% | 6.4% | 5.5% | 5.4% |

Note: All tabular comparisons included in the following discussion, unless otherwise indicated, are for the three months ended May 3, 2020 (Q2 FY20), February 2, 2020 (Q1 FY20) and April 28, 2019 (Q2 FY19), and for the six months ended May 3, 2020 (YTD FY20) and April 28, 2019 (YTD FY19), in millions of dollars.

### Revenue

Our quarterly revenues can be affected by the seasonal purchasing practices of our customers. As a result, demand for our products is typically reduced during the first, and sometimes the second, quarters of our fiscal year, by the North American, European, and Asian holiday periods, as some of our customers reduce their development and, consequently, their buying activities during those periods.

At the beginning of fiscal year 2020, we changed the threshold for the definition of high-end FPD, from G8 and above and active matrix organic light-emitting diode (AMOLED) display screens, to G10.5 and above, AMOLED, and low-temperature polysilicon display screens (LTPS), to reflect the overall advancement of technology in the FPD industry. Our definition of high-end IC products remains as 28 nanometer or smaller. The following analyses of quarterly changes in revenue by product type for the three-month periods ended February 2, 2020 and April 28, 2019, and the six-month period ended April 28, 2019, have been modified to reflect this change. High-end photomasks typically have higher selling prices (ASPs) than mainstream products.

The following tables present changes in disaggregated revenue in Q2 FY20 and YTD FY20 from revenue in prior reporting periods. Columns may not total due to rounding.

#### Quarterly Changes in Revenue by Product Type

| IC | Q2 FY20 from Q1 FY20 Revenue in Q2 FY20 | Increase (Decrease) | Percent Change | Q2 FY20 from Q2 FY19 Increase (Decrease) | Percent Change | YTD FY20 from YTD FY19 Revenue in YTD FY20 | Increase (Decrease) | Percent Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| High-end | $38.3 | $(2.8) | (6.8)% | $(0.2) | (0.4)% | $79.3 | $6.3 | 8.6% |
| Mainstream | 58.6 | (7.4) | (11.2)% | (1.6) | (2.6)% | 124.5 | 4.0 | 3.4% |
| Total IC | $96.8 | $(10.1) | (9.5)% | $(1.7) | (1.8)% | $203.8 | $10.4 | 5.4% |
| FPD |  |  |  |  |  |  |  |  |
| High-end | $31.8 | $(8.0) | (20.0)% | $9.8 | 44.2% | $71.6 | $34.2 | 91.4% |
| Mainstream | 14.1 | 1.1 | 8.7% | 3.2 | 29.0% | 27.1 | 1.7 | 6.6% |
| Total FPD | $45.9 | $(6.8) | (12.9)% | $12.9 | 39.2% | $98.7 | $35.9 | 57.1% |
| Total Revenue | $142.8 | $(17.0) | (10.6)% | $11.2 | 8.5% | $302.5 | $46.2 | 18.0% |

#### Quarterly Changes in Revenue by Geographic Origin

|  | Q2 FY20 from Q1 FY20 Revenue in Q2 FY20 | Increase (Decrease) | Percent Change | Q2 FY20 from Q2 FY19 Increase (Decrease) | Percent Change | Revenue in YTD FY20 | YTD FY20 from YTD FY19 Increase (Decrease) | Percent Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Taiwan | $55.5 | $(10.6) | (16.0)% | $(1.0) | (1.7)% | $121.6 | $7.4 | 6.5% |
| Korea | 36.3 | (4.5) | (11.0)% | (1.8) | (4.7)% | 77.0 | 3.7 | 5.1% |
| United States | 24.9 | (0.2) | (0.8)% | (1.9) | (7.0)% | 49.9 | 0.7 | 1.4% |
| Europe | 8.3 | 0.8 | 10.4% | (0.1) | (1.2)% | 15.9 | (0.9) | (5.4)% |
| China | 17.5 | (2.4) | (12.1)% | 16.0 | 1,091.8% | 37.4 | 35.7 | 2,060.9% |
| Other | 0.3 | 0.0 | (13.2)% | (0.1) | (24.0)% | 0.7 | (0.4) | (34.7)% |
|  | $142.8 | $(17.0) | (10.6)% | $11.2 | 8.5% | $302.5 | $46.2 | 18.0% |

Revenue decreased $17.0 million, or 10.6%, in Q2 FY20, compared with Q1 FY20, primarily due to push-outs of orders, first in China, due to the extended Lunar New Year period and concomitant reductions in manufacturing activity attributable to the coronavirus pandemic, and then in our other sites, as we encountered mobility restrictions due to the pandemic. The greatest impact of these restrictions was experienced in the mainstream IC and high-end FPD product lines. On a geographic basis, Asia revenue declined in varying degrees, the U.S. revenue was essentially flat, and Europe revenue increased $0.8 million or 10.4%. Most of our IC customers’ products have been deemed to be essential. However, with many of their design teams working remotely, design verification processes have been delayed, resulting in delays in their orders. Our three FPD facilities operated at capacity in Q2 FY20, but orders for G10.5+ products decreased from Q1 FY20, resulting in lower high-end and total FPD revenue in the current quarter.

Revenue increased 8.5% in Q2 FY20, compared with Q2 FY19, due to increased high-end and mainstream FPD revenues. The increases reflected both stronger global demand and our increased ability to meet it through the utilization of our China-based FPD factory. IC revenues declined moderately by 1.8%, as design releases were behind schedule due to delays in design verification processes. On a geographic basis, the increase in revenue was attributable to revenues in our two China-based facilities.

On a year-to-date basis, revenues increased $46.2 million, or 18.0%, from YTD FY19, resulting from growth in all product categories, led by high-end FPD, which grew $34.2 million, or 91.4%, from the prior year period. While this growth was led by increased revenues from G10.5+ products, there were also significant increases in revenues from both AMOLED and LTPS products. On a geographic basis, approximately 77% of the increase was attributable to revenues in our two China-based sites.

### Gross Margin

|  | Three Months Ended Q2 FY20 | Q1 FY20 | Percent Change | Q2 FY19 | Percent Change | Six Months Ended YTD FY20 | YTD FY19 | Percent Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Gross profit | $30.4 | $34.6 | (12.0)% | $26.0 | 17.0% | $65.0 | $52.1 | 24.8% |
| Gross margin | 21.3% | 21.7% |  | 19.8% |  | 21.5% | 20.3% |  |

Gross margin decreased by 0.4% in Q2 FY20, from Q1 FY20, primarily as a result of the previously discussed 10.6% decrease in revenue. Total cost of goods sold decreased 10.2%, with the primary drivers being: an 11.8% decrease in material costs, reflecting the decrease in revenue; a decrease in compensation and related costs of 10.3%; a decrease in overhead costs of 8.9%, as variable and discretionary expenses declined in most categories, with the most notable exception being tool maintenance, which increased $0.6 million, or 11.3%.

Gross margin increased by 1.5 percentage points in Q2 FY20, from Q2 FY19, primarily as a result of the 8.5% growth in revenue in the current year quarter. Material costs, as a percent of revenue, increased 1.0%, in contrast to labor costs, which decreased by 1.8 percentage points as a percent of revenue. Overhead costs increased 6.2%, with depreciation at our two China-based facilities, both of which began production in fiscal year 2019, the predominant cause. Net of depreciation at the China-based facilities, overhead costs decreased 1.0% from the prior year quarter.

Gross margin increased by 1.2% in YTD FY20, from YTD FY19, primarily as a result of the 18.0% increase in revenue. Material costs, as a percent of revenue, increased 1.1 percentage points, in contrast to labor costs, which fell 1.7%, as a percent of revenue. Overhead costs increased 16.8%, with depreciation at our two China-based facilities, which began production in FY19, accounting for approximately half of the increase. Other outside services and other equipment related costs were up 27.5% and 15.6%, respectively, contributing significantly to the overall increase in overhead costs.

As we operate in a high fixed cost environment, increases or decreases in our revenues and capacity utilization will generally positively or negatively impact our gross margin.

### Selling, General and Administrative Expenses

Selling, general and administrative expenses decreased by $1.0 million, or 6.7%, to $13.3 million in Q2 FY20, from $14.2 million in Q1 FY20, primarily due to decreased compensation and related expenses. Selling, general and administrative expenses was unchanged from Q2 FY19, decreasing by 0.8 percentage points, as a percent of revenue. Selling, general and administrative expenses increased by $0.4 million, or 1.5%, to $27.5 million in YTD FY20, from $27.1 million in YTD FY19, primarily due to increased compensation and related expenses.

### Research and Development Expenses

Research and development expenses consist of development efforts generally related to process technologies for high-end IC nodes and FPD applications.

Research and development expense increased $0.4 million, to $4.5 million, or 9.4%, in Q2 FY20, from Q1 FY20, primarily as a result of increased FPD development activities in China and IC development activities in the U.S. Research and development expense increased $ 0.9 million, or 26.0%, in Q2 FY20, from Q2 FY19, due to increased spending in the U.S. and the two China-based facilities. Research and development expense increased $ 0.7 million, or 9.4%, in YTD FY20, from YTD FY19, primarily due to increased development activities at the two China-based facilities, which were partially offset by reduced activities in the U.S.

### Other Income (Expense)

|  | Three Months Ended Q2 FY20 | Q1 FY20 | Q2 FY19 | Six Months Ended YTD FY20 | YTD FY19 |
| --- | ---: | ---: | ---: | ---: | ---: |
| Foreign currency transaction (losses) gains, net | $(1.4) | $4.7 | $4.0 | $3.3 | $5.1 |
| Interest expense, net | 0.8 | (1.8) | (0.4) | (1.0) | (0.9) |
| Interest income and other income (expense), net | (0.3) | 0.8 | 0.3 | 0.5 | 0.9 |
| Other income (expense), net | $(1.0) | $3.7 | $3.9 | $2.8 | $5.0 |

Other income (expense), net decreased $4.7 million from income of $3.7 million in Q1 FY20 to a loss of $1.0 million in Q2 FY20, primarily due to an unfavorable change in foreign currency transaction results of $6.1 million, partially offset by the receipt of interest subsidies in Q2 F20. Other income (expense), net decreased by $4.9 million, from income of $3.9 million in Q2 FY19, to the loss of $1.0 million in Q2 FY20; this loss was primarily due to an unfavorable change in foreign currency transaction results of $5.4 million. Other income (expense), net decreased $2.2 million year-to-date primarily due to a decrease in foreign currency exchange gains of $1.8 million in YTD FY20, compared with the prior year period.

### Income Tax Provision

|  | Three Months Ended Q2 FY20 | Q1 FY20 | Q2 FY19 | Six Months Ended YTD FY20 | YTD FY19 |
| --- | ---: | ---: | ---: | ---: | ---: |
| Income tax provision | $3.8 | $9.1 | $3.3 | $12.9 | $4.7 |
| Effective income tax rate | 32.2% | 45.4% | 25.0% | 40.5% | 20.9% |

The effective income tax rate is sensitive to the jurisdictional mix of earnings, due, in part, to the non-recognition of tax benefits on losses in jurisdictions with valuation allowances.

The effective income tax rate decreased in Q2 FY20, compared with Q1 FY20, primarily due to the establishment of a valuation allowance for a loss carryforward in a non-U.S. jurisdiction in Q1 FY20 and changes in the jurisdictional mix of earnings. The effective income tax rate increased in Q2 FY20, compared with Q2 FY19, due to changes in the jurisdictional mix of earnings and the expiration of a tax holiday in Taiwan in December 2019.

The effective income tax rate increased in YTD FY20, compared with YTD FY19, primarily due to the YTD FY20 establishment of a valuation allowance for a loss carryforward in a non-U.S. jurisdiction, which was partially offset by a non-repetitive, one-time audit settlement benefit in YTD FY19, as well as changes in the jurisdictional mix of earnings, the expiration of a tax holiday in Taiwan, and use of investment credits to reduce tax expense in 2019.

### Net Income Attributable to Noncontrolling Interests

Net income attributable to noncontrolling interests was $1.7 million in Q2 FY20, which represented an increase of $1.1 million from Q1 FY20, as a decreased loss at our China-based IC facility exceeded decreased income at our Taiwan-based IC facility. Net income attributable to noncontrolling interests increased $0.3 million in Q2 FY20 from $1.4 million in Q2 FY19, as a result of increased income at our Taiwan-based IC facility, and a decreased loss at our China-based IC facility. On a year-to-date basis, net income attributable to noncontrolling interests decreased $1.6 million; the decrease was the result of an increased loss at the China-based facility, which was partially offset by increased income at the Taiwan-based facility. We hold 50.01% ownership interests in both of these facilities.

### Liquidity and Capital Resources

We had cash and cash equivalents of $237.8 million at the end of Q2 FY20, compared with $206.5 million at the end of fiscal 2019. The net increase is primarily attributable to:

- $61.3 million provided by operating activities;
- $7.6 million contributed to our China-based IC facility by noncontrolling interests;
- $5.3 million government incentives received in China;
- $3.4 million received from exercises of employee stock options;
- $1.1 million received from borrowings in China;
- $30.1 million paid for property, plant, and equipment;
- $16.9 million used to repurchase our common stock.

Our working capital at the end of Q2 FY20 was $318.9 million, compared with $275.6 million at the end of fiscal 2019. The $43.3 million net increase is primarily attributable to the below increases (decreases) in working capital:

- Increased cash and cash equivalents of $31.3 million;
- Increased inventories of $8.8 million, acquired to protect against potential COVID 19 related supply chain disruptions;
- Increased recoverable value added taxes of $6.2 million, related to our China-based facilities;
- Decreased discretionary compensation accruals of $5.3 million;
- Decreased accruals for capital expenditures of $4.6 million;
- Increased current portion of long-term debt of $(6.8) million;
- Increased value added taxes payable of $(6.3) million.

The net cash provided by operating activities of $61.3 million in YTD FY20 was a $63.6 million increase from $2.3 million used in YTD FY19. The net increase was primarily due to:

- Increased net income of $1.3 million in YTD FY20;
- Increased non-cash add backs to net income, including depreciation, share-based compensation and deferred income taxes of $10.2 million in YTD FY20;
- A comparative decrease in value added tax prepayments related to our China facilities of $25.1 million inQ1 FY20. These prepayments are recoverable through future revenue transactions of the facilities;
- A comparative decrease in the increase of prepaid income taxes of $2.8 million in YTD FY20;
- Increased operating lease liabilities of $1.8 million, which resulted from our adoption of ASC 842 in Q1 FY20.

Net cash used in investing activities was $25.0 million in YTD FY20, a decrease of $109.8 million from the $134.8 million used in YTD FY19. The net decrease was primarily attributable to decreased capital expenditures of $110.3 million; this was the result of a reduction in payments to equip our China-based facilities, which were in the start-up phase in the first half of fiscal year 2019.

Net cash flows used in financing activities decreased to $5.4 million in YTD FY20 from $28.0 million used in YTD FY19. Significant components of the $22.6 million net decrease were:

- $57.5 million used to repay (upon their maturity) our convertible senior notes in YTD FY19;
- $26.1 million used to pay dividends to DNP (related to their 49.99% interest in our IC facility in Taiwan) in YTD FY19;
- $(38.5) million less received from borrowings in China in YTD FY20 than in YTD FY19;
- $(21.8) million less contributed by DNP to maintain their proportionate ownership interest in our IC joint venture in China in YTD FY20 than in YTD FY19.

As of May 3, 2020 and October 31, 2019, our total cash and cash equivalents included $192.7 million and $147.2 million, respectively, held by our foreign subsidiaries. The majority of earnings of our foreign subsidiaries are considered to be indefinitely reinvested. Repatriation of these funds to the U.S. may subject them to U.S. state income taxes and local country withholding taxes in certain jurisdictions. Furthermore, our foreign subsidiaries continue to grow through the reinvestment of earnings in additional manufacturing capacity and capability, particularly in the high-end IC and FPD areas.

Our liquidity, as we operate in a high fixed cost environment, is highly dependent on our revenue, cash conversion cycle, and the timing of our capital expenditures (which can vary significantly from period to period). We believe that our cash on hand, cash generated from operations, and amounts available to borrow will be sufficient to meet our cash requirements for the next twelve months. However, depending on conditions in the semiconductor and FPD markets, our cash flows from operations and current holdings of cash may not be adequate to meet our current and long-term needs for capital expenditures, operations and debt repayments. Historically, in certain years, we have used external financing to fund these needs. Due to conditions in the credit markets and covenant restrictions on our existing debt, some financing instruments we have used in the past may not be available to us when required. Consequently, we cannot assure that additional sources of financing would be available to us on commercially favorable terms, should our long-term cash requirements exceed our existing cash and cash available under our credit agreements (which are discussed in Note 5 to the condensed consolidated financial statements).

As of May 3, 2020, we had outstanding capital commitments of approximately $138 million. We intend to finance our capital expenditures with our working capital, contributions from our joint venture partners, borrowings under the MLA we entered into in fiscal 2019 (as discussed in Note 5 to the condensed consolidated financial statements), cash generated from operations and, if necessary, additional borrowings. Our remaining funding commitment for our IC facility in China, which commenced production in the third quarter of fiscal 2019, was approximately $8 million as of May 3, 2020; we fulfilled this commitment in May 2020.

### Off-Balance Sheet Arrangements

As noted above, in January 2018, Photronics, through its wholly owned Singapore subsidiary, entered into the PDMCX joint venture with DNP, through its wholly owned subsidiary “DNP Asia Pacific PTE, Ltd.” under which DNP obtained a 49.99% interest in our IC business in Xiamen, China. The joint venture was established to develop and manufacture photomasks for leading edge and advanced generation semiconductors. Under the joint venture’s operating agreement, DNP is afforded, under certain circumstances, the right to put its interest in PDMCX to Photronics. These circumstances include disputes regarding the strategic direction of PDMCX that may arise after the initial two-year term of the Agreement that cannot be resolved between the two parties. As of the date of issuance of this report, DNP had not indicated its intention to exercise this right. In addition, both Photronics and DNP have the option to purchase, or put, their interest from, or to, the other party, should their ownership interest fall below 20% for a period of more than six consecutive months. Under all such circumstances, the sales of ownership interests would be at the exiting party’s ownership percentage of the joint venture’s net book value, with closing to take place within three business days of obtaining required approvals and clearance. Should DNP exercise an option to put their, or purchase our, interest in PDMCX we may, depending on the relationship of the fair and book value of PDMCX’s net assets, incur a loss. As of May 3, 2020, Photronics and DNP each had net investments in PDMCX of $43.0 million.

### Business Outlook

While the near-term effects of the global coronavirus pandemic on our business cannot be predicted, we continue to believe that a majority of the growth in the IC and FPD markets will continue to come from the Asia region, predominantly in China. We expect to meet these demands both through the utilization of our new facilities in China, and by importing photomasks into China from our other facilities. We make continual assessments of our global manufacturing strategy and monitor our revenue and related cash flows from operations. These ongoing assessments could result in future facility closures, asset redeployments, impairments of intangible or long-lived assets, workforce reductions, or the addition of manufacturing facilities, all of which would be based on market conditions and customer requirements.

Our future results of operations and the other forward-looking statements contained in this filing involve a number of risks and uncertainties, some of which are discussed in Part1, Item 1A in our Annual Report on Form 10-K for the year ended October 31, 2019 and in Part 2, Item 1A in our Quarterly Report on Form 10-Q for the quarter ended February 2, 2020; a number of other unforeseen factors could cause actual results to differ materially from our expectations.

### Effect of Recent Accounting Pronouncements

See “Item 1. Condensed Consolidated Financial Statements– Notes to Condensed Consolidated Financial Statements – Note 15 – Recent Accounting Pronouncements” for recent accounting pronouncements that may affect the Company’s financial reporting.

## Market risk

As filed, 3,297 characters.

### Foreign Currency Exchange Rate Risk

We conduct business in several major international currencies throughout our worldwide operations, and our financial performance may be affected by fluctuations in the exchange rates of these currencies. Changes in exchange rates can positively or negatively affect our reported revenue, operating income, assets, liabilities, and equity. The functional currencies of our Asian subsidiaries are the South Korean won, the New Taiwan dollar, the Chinese renminbi, and the Singapore dollar. The functional currencies of our European subsidiaries are the British pound and the euro. In addition, we engage in transactions in, and have exposures to, the Japanese yen.

We attempt to minimize our risk of foreign currency transaction losses by producing products in the same country in which the products are sold (thereby generating revenues and incurring expenses in the same currency), and by managing our working capital. However, in some instances, we sell products in a currency other than the functional currency of the country where it was produced, or purchase products in a currency that differs from the functional currency of the purchasing entity. In addition, to the extent practicable, we attempt to reduce our exposure to foreign currency exchange fluctuations by converting cash and cash equivalents into the functional currency of the subsidiary which holds the cash. We may also enter into derivative contracts to mitigate our exposure to foreign currency fluctuations when we have a significant purchase obligation, or a significant receivable denominated in a currency that differs from the functional currency of the transacting subsidiary. We do not enter into derivatives for speculative purposes. There can be no assurance that this approach will protect us from the need to recognize significant foreign currency transaction gains and losses, especially in the event of a significant adverse movement in the value of any foreign currency in which we conduct business against any of our functional currencies, including the U.S. dollar.

Our primary net foreign currency exposures as of May 3, 2020, included the South Korean won, the Japanese yen, the New Taiwan dollar, the Chinese renminbi, the Singapore dollar, the British pound sterling, and the euro. As of that date, a 10% adverse movement in the value of currencies different than the functional currencies of our subsidiaries would have resulted in a net unrealized pre-tax loss of $33.1 million, which represents a decrease of $0.8 million from our exposure at February 2, 2020, and is equivalent to our exposure at October 31, 2019. Our most significant exposures at May 3, 2020, related to the Chinese renminbi and the South Korean won to the U.S. dollar, which were, respectively, $13.3 million and $11.8 million at that date. We do not believe that a 10% change in the exchange rates of non-US dollar currencies, other than the aforementioned currencies and the Japanese Yen, would have had a material effect on our May 3, 2020, condensed consolidated financial statements.

### Interest Rate Risk

A 10% adverse movement in the interest rates on our variable rate borrowings would not have had a material effect on our May 3, 2020 condensed consolidated financial statements.

## Controls and procedures

As filed, 1,927 characters.

### Evaluation of Disclosure Controls and Procedures

We have established and currently maintain disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), designed to provide reasonable assurance that information required to be disclosed in reports filed under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms, and that such information is accumulated and communicated to management, including our chief executive officer and chief financial officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Our management, under the supervision and with the participation of our chief executive officer and chief financial officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report. Based upon that evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were effective at a reasonable assurance level as of the end of the period covered by this report.

### Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting during the second fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 4,479 characters.

Other than the below, there have been no other material changes to risks relating to our business as disclosed in Part 1, Item 1A of our Annual Report on Form 10-K for the year ended October 31, 2019 and Part 2, Item 1A of our Quarterly Report on Form 10-Q for the quarter ended February 2, 2020.

### Our expansion into China entails substantial risks.

In the past year, we commenced operations at our two newly constructed manufacturing facilities in China. These investments are subject to substantial risks which may include, but are not limited to: the inability to protect our intellectual property rights under Chinese law, which may not offer as high a level of protection as U.S. law; unexpectedly long negotiation periods with Chinese suppliers and customers; quality issues related to materials sourced from local vendors; unexpectedly high labor costs due to a tight labor supply; and difficulty in repatriating funds and selling or transferring assets. Our investments in China also expose us to a significant additional foreign currency exchange risk, which we had not been subject to in recent years. In addition, while we do not see any imminent threat, as tensions have escalated between the U.S. and China, we believe there is an enhanced risk that our substantial investments in China may be subject to unforeseen restrictions, which may include expropriation of the investments by the Chinese government. These and other risks may result in our not realizing a return on, or losing some, or all, of our planned investments in China, which would have a material adverse effect on our financial condition and financial performance.

**Our business could be adversely impacted by global or regional catastrophic events.**

Our business could be adversely affected by terrorist acts, widespread outbreaks of infectious diseases (such as the COVID-19 pandemic), government responses such as shelter-in-place directives to limit the impact of infectious diseases, or the outbreak or escalation of wars, especially in the Asian markets in which we generate a significant portion of our sales and in Japan where we purchase raw materials and capital equipment. Such events in the geographic regions in which we do business, including escalations of political tensions and military conflicts within the Korean Peninsula, or between the People’s Republic of China and the U.S. or the Republic of China (Taiwan), could have material adverse impacts on our revenue, cost and availability of raw materials, results of operations, cash flows, and financial condition.

### Our products and technology could be subject to U.S. export control laws and the export control laws of the foreign jurisdictions where we operate

We are subject to various laws relating to the export of products we manufacture and the technology related thereto, and our failure to comply with these laws could subject us to substantial fines, penalties and even injunctions, the imposition of which could have a material adverse effect on the success of our business.

We are subject to the export control laws of the United States and the export control laws of the foreign jurisdictions where we operate. On April 28, 2020, the Trump administration significantly expanded the reach of U.S. export controls over certain products and certain countries. The U.S. Department of Commerce has, among other things: expanded license requirements to China, Russia and Venezuela; broadened the list of products covered by these expanded license requirements; expanded the definition of “military end use”; created a new “reason for control”; created a new review policy for certain items to certain countries; added substantial electronic export information filing requirements; eliminated the license exception for civil end use for certain countries, including China, Russia and Venezuela; and proposed to remove those same countries from the list of those eligible for additional re-exports license exceptions. The final rules relating to most of these changes are effective June 29, 2020, and comments to the proposed rule on re-exports are due on the same day. Application of these laws may adversely affect our business in various ways, including by regulating the export of our products, equipment, services, and technology from the United States and abroad, increasing the time necessary to obtain required authorizations, and the possibility of monetary fines and other penalties for non-compliance.

Filed Jun 12, 2020.
Source: SEC EDGAR, the filing index for accession 0001140361-20-013682. Last ingested by Listed: Nov 15, 2026, 01:00 ET. No prices; not investment advice.
